Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients

ABSTRACT: Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients

PROVIDER: PRJNA682214 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients [undergoing and post therapy]

Project description:Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients [undergoing and post therapy]

| PRJNA682216 | ENA

Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients [undergoing and post therapy]

Project description:Genome wide DNA methylation profiling of paired samples from childhood cancer patients undergoing chemotherapy treatment, using the Illumina Infinium Human MethylationEPIC Beadchip arrays. Samples included 32 paired samples (i.e. total 64 samples), with the second sample taken after treatment . Specific therapies and duration between samples varied.

2020-12-31 | GSE162554 | GEO

Epigenome analysis altered DNA methylation in survivors of childhood and young adult cancer [adult]

Project description:Epigenome analysis altered DNA methylation in survivors of childhood and young adult cancer [adult]

| PRJNA682217 | ENA

Epigenome analysis altered DNA methylation following chemotherapy in childhood cancer patients

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-12-31 | GSE162560 | GEO

Altered hippocampal transcriptome dynamics following sleep deprivation

Project description:Altered hippocampal transcriptome dynamics following sleep deprivation

| PRJNA702096 | ENA

Epigenome analysis altered DNA methylation in survivors of childhood and young adult cancer [adult]

Project description:Genome wide DNA methylation profiling of samples from adult survivors of childhood and young adult cancer, using the Illumina Infinium Human MethylationEPIC Beadchip arrays. Samples included 32 samples, all sampled at least 10 years after diagnosis . Specific therapies and duration between sampling and diagnosis varied.

2020-12-31 | GSE162559 | GEO

Extracellular vesicle proteome of breast cancer patients with and without cognitive impairment following anthracycline-based chemotherapy

Project description:Cognitive impairment due to cancer and its therapy is a major concern among cancer survivors. Extracellular vesicles (EVs) composition altered by cancer and chemotherapy may affect neurological processes such as neuroplasticity, potentially impacting the cognitive abilities of cancer survivors. We investigated the EV proteome of breast cancer patients with and without cognitive impairment following anthracycline-based chemotherapy from longitudinally collected plasma. EVs were cup-shaped and positive for Flotillin-1 and TSG-101. We identified 517 differentially expressed EV proteins between the cognitive impaired and non-impaired groups during and post-chemotherapy. The observed decreased expression of p2X purinoceptor, cofilin-1, ADAM 10, and dynamin-1 in the plasma EVs of cognitive impaired group may suggest alterations in mechanisms underlying synaptic plasticity. The reduced expression of tight junction proteins among cognitive-impaired patients may imply weakening of the blood-brain barrier. These EV protein signatures may serve as a fingerprint that underscore the mechanisms underlying cognitive impairment in cancer survivors.

2021-05-27 | PXD021395 | Pride

Epigenome analysis of pre- and post-neoadjuvant chemotherapy breast tumor samples

Project description:Epigenome analysis of pre- and post-neoadjuvant chemotherapy breast tumor samples

| PRJNA416463 | ENA

Modulation of the mouse liver epigenome following TCPOBOP exposure

Project description:Modulation of the mouse liver epigenome following TCPOBOP exposure

| PRJNA408126 | ENA

Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer

Project description:This SuperSeries is composed of the following subset Series: GSE25055: Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer GSE25065: Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer Refer to individual Series

2011-05-11 | E-GEOD-25066 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data